Skip to content

Tai Chi Mind-Body Therapy for Chronic Heart Failure

Tai Chi Mind-Body Therapy for Chronic Heart Failure

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00110227
Acronym
NEXT-Heart
Enrollment
100
Registered
2005-05-05
Start date
2005-09-30
Completion date
2009-07-31
Last updated
2017-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Complementary Therapies, Tai Chi

Brief summary

The purpose of this study is to determine the effects of a tai chi exercise program on functional capacity and health-related quality of life in patients with chronic heart failure (HF). This study will also examine the way tai chi influences mental, physical, and social functioning.

Detailed description

HF is a major public health problem in the United States, affecting approximately 5 million adults. Despite recent advances in pharmacologic therapy and technologic devices, HF is the most common reason for hospitalization among Medicare patients and is reaching epidemic proportions as the population ages. New and inexpensive interventions that can improve functional capacity and quality of life and can delay disease progression are needed. Tai chi is a popular mind-body exercise that is a potential treatment for heart disease. This exercise incorporates both gentle physical activity and meditation, and it may be particularly suited to frail patients with HF. This study will examine the effects of a tailored tai chi program on functional capacity and quality of life in patients with HF. Participants will be randomly assigned to either a tai chi program or heart health education for 12 weeks. Participants in both groups will undergo a bicycle stress test at study entry and will receive weekly training sessions of their assigned intervention. Self-report scales and questionnaires will be used to assess participants at study start and at the end of 12 weeks.

Interventions

BEHAVIORAL12-week Tai Chi Program

24 tai chi sessions. 2 sessions/week for 12 weeks.

BEHAVIORAL12-week Education Program

24 Educational sessions. 2 sessions/week for 12 weeks.

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH
Beth Israel Deaconess Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of chronic HF * Percentage of blood pumped from the left ventricle (ventricular ejection fraction) less than 40% for at least 1 year prior to study entry * Stable medical regimen, defined as no major changes in medication, in the 3 months prior to study entry * New York Heart Association Classification of Class I (no activity limitations), Class II (slight activity limitations), or Class III (marked activity limitations) * English-speaking

Exclusion criteria

* Unstable angina, myocardial infarction, cardiac resynchronization, or major cardiac surgery within 3 months prior to study entry * History of cardiac arrest or diagnosis of peripartum cardiomyopathy within 6 months prior to study entry * Unstable ventricular arrhythmias or structural valvular disease * Current participation in a conventional cardiac rehabilitation program * Inability to perform a bicycle stress test at study entry * Lower extremity amputation or other inability to walk due to conditions other than HF * Severe cognitive dysfunction preventing informed consent and understanding of tai chi concept * Current regular practice of tai chi * Current participation in a tai chi pilot study or other studies

Design outcomes

Primary

MeasureTime frame
HF-specific quality of lifebaseline, midpoint, endpoint, 6mo
functional capacitybaseline and endpoint
Walking Testbaseline, midpoint, endpoint

Secondary

MeasureTime frame
sense of coherencebaseline, midpoint, endpoint, 6mo
utility assessmentbaseline, midpoint, endpoint, 6mo
beliefs, attitudes, and expectationsbaseline, midpoint, endpoint
physical activity levelbaseline, midpoint, endpoint
General quality of lifebaseline, midpoint, endpoint, 6mo
neurohormonal statusbaseline, midpoint, endpoint
autonomic tone, heart rate variabilitybaseline and endpoint
echocardiographybaseline and endpoint
costs and use of HF servicesbaseline and endpoint
perceived social supportbaseline, midpoint, endpoint
mood and emotional statusbaseline, midpoint, endpoint, 6mo
exercise self-efficacybaseline, midpoint, endpoint, 6mo

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 29, 2026